Cargando…

Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg

At a meeting held on 20 May 2021, reviewed the available literature on the use of the medicinal product Bijuva® for the relief of menopausal symptoms.

Detalles Bibliográficos
Autores principales: Bińkowska, Małgorzata, Jakiel, Grzegorz, Paszkowski, Tomasz, Skrzypulec-Plinta, Violetta, Zgliczyński, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525257/
https://www.ncbi.nlm.nih.gov/pubmed/34703410
http://dx.doi.org/10.5114/pm.2021.109887
_version_ 1784585651272810496
author Bińkowska, Małgorzata
Jakiel, Grzegorz
Paszkowski, Tomasz
Skrzypulec-Plinta, Violetta
Zgliczyński, Wojciech
author_facet Bińkowska, Małgorzata
Jakiel, Grzegorz
Paszkowski, Tomasz
Skrzypulec-Plinta, Violetta
Zgliczyński, Wojciech
author_sort Bińkowska, Małgorzata
collection PubMed
description At a meeting held on 20 May 2021, reviewed the available literature on the use of the medicinal product Bijuva® for the relief of menopausal symptoms.
format Online
Article
Text
id pubmed-8525257
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-85252572021-10-25 Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg Bińkowska, Małgorzata Jakiel, Grzegorz Paszkowski, Tomasz Skrzypulec-Plinta, Violetta Zgliczyński, Wojciech Prz Menopauzalny Featured Paper At a meeting held on 20 May 2021, reviewed the available literature on the use of the medicinal product Bijuva® for the relief of menopausal symptoms. Termedia Publishing House 2021-10-11 2021-09 /pmc/articles/PMC8525257/ /pubmed/34703410 http://dx.doi.org/10.5114/pm.2021.109887 Text en Copyright © 2021 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) )
spellingShingle Featured Paper
Bińkowska, Małgorzata
Jakiel, Grzegorz
Paszkowski, Tomasz
Skrzypulec-Plinta, Violetta
Zgliczyński, Wojciech
Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg
title Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg
title_full Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg
title_fullStr Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg
title_full_unstemmed Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg
title_short Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg
title_sort position statement by experts of the polish menopause and andropause society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg
topic Featured Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525257/
https://www.ncbi.nlm.nih.gov/pubmed/34703410
http://dx.doi.org/10.5114/pm.2021.109887
work_keys_str_mv AT binkowskamałgorzata positionstatementbyexpertsofthepolishmenopauseandandropausesocietyonmenopausalhormonetherapywithanoralcombinationdrugcontainingoestradiol1mgandprogesterone100mg
AT jakielgrzegorz positionstatementbyexpertsofthepolishmenopauseandandropausesocietyonmenopausalhormonetherapywithanoralcombinationdrugcontainingoestradiol1mgandprogesterone100mg
AT paszkowskitomasz positionstatementbyexpertsofthepolishmenopauseandandropausesocietyonmenopausalhormonetherapywithanoralcombinationdrugcontainingoestradiol1mgandprogesterone100mg
AT skrzypulecplintavioletta positionstatementbyexpertsofthepolishmenopauseandandropausesocietyonmenopausalhormonetherapywithanoralcombinationdrugcontainingoestradiol1mgandprogesterone100mg
AT zgliczynskiwojciech positionstatementbyexpertsofthepolishmenopauseandandropausesocietyonmenopausalhormonetherapywithanoralcombinationdrugcontainingoestradiol1mgandprogesterone100mg